Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.

Shehu-Xhilaga M, Rhodes D, Wightman F, Liu HB, Solomon A, Saleh S, Dear AE, Cameron PU, Lewin SR.

AIDS. 2009 Sep 24;23(15):2047-50. doi: 10.1097/QAD.0b013e328330342c.

PMID:
19609198
2.

Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.

Quivy V, De Walque S, Van Lint C.

Subcell Biochem. 2007;41:371-96. Review.

PMID:
17484137
3.

Reactivation of latent HIV by histone deacetylase inhibitors.

Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E.

Trends Microbiol. 2013 Jun;21(6):277-85. doi: 10.1016/j.tim.2013.02.005. Epub 2013 Mar 18. Review.

4.
5.

Histone deacetylase inhibitors as new cancer drugs.

Marks PA, Richon VM, Breslow R, Rifkind RA.

Curr Opin Oncol. 2001 Nov;13(6):477-83. Review.

PMID:
11673688
6.

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges.

Atadja P.

Cancer Lett. 2009 Aug 8;280(2):233-41. doi: 10.1016/j.canlet.2009.02.019. Epub 2009 Apr 2. Review.

PMID:
19344997
7.

Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.

Van Lint C, Quivy V, Demonté D, Chariot A, Vanhulle C, de Walque S, Gaudray G, Veithen E, Bours V, Piette J, Burny A.

Bull Mem Acad R Med Belg. 2004;159(Pt 2):176-89. Review.

PMID:
15615091
8.
9.

Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors.

Manson McManamy ME, Hakre S, Verdin EM, Margolis DM.

Antivir Chem Chemother. 2014 Jan 29;23(4):145-9. doi: 10.3851/IMP2551. Review.

10.

HDAC inhibitors in HIV.

Wightman F, Ellenberg P, Churchill M, Lewin SR.

Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15. Review.

PMID:
22083528
11.

[Molecular basis of HIV-1 latency - Part II: HIV-1 reactivation and therapeutic implications].

Cherrier T, Le Douce V, Redel L, Marban C, Aunis D, Rohr O, Schwartz C.

Med Sci (Paris). 2010 Mar;26(3):291-5. doi: 10.1051/medsci/2010263291. Review. French.

12.

Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.

Matalon S, Rasmussen TA, Dinarello CA.

Mol Med. 2011 May-Jun;17(5-6):466-72. doi: 10.2119/molmed.2011.00076. Epub 2011 Mar 15. Review.

13.

Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Planelles V, Wolschendorf F, Kutsch O.

Curr HIV Res. 2011 Dec 1;9(8):568-78. Review.

Supplemental Content

Support Center